| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Schimmel Paul is a Director at aTYR PHARMA INC with holdings across 3 companies. Recent SEC Form 4 filings include 4 buys and 3 sells.
Estimated insider holdings value: $4.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 8, 2016 | ATYR Atyr Pharma Inc | Director | Buy | 85,000 | $3.22 | $273,649.00 | +82.9% | |
| Apr 7, 2016 | ATYR Atyr Pharma Inc | Director | Buy | 40,000 | $3.19 | $127,584.00 | +63.9% | |
| Apr 6, 2016 | ATYR Atyr Pharma Inc | Director | Buy | 25,000 | $3.20 | $80,000.00 | +66.5% | |
| Apr 5, 2016 | ATYR Atyr Pharma Inc | Director | Buy | 25,000 | $3.52 | $88,117.50 | +198.9% | |
| Apr 21, 2015 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 10,000 | $130.02 | $1,300,200.00 | -100% | |
| Mar 19, 2015 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 10,000 | $120.00 | $1,200,000.00 | -100% |